Literature DB >> 22776646

A model of nitric oxide induced α-synuclein misfolding in Parkinson's disease.

David K Stone1, Tomomi Kiyota, R Lee Mosley, Howard E Gendelman.   

Abstract

Inducible nitric oxide synthase (iNOS) upregulation and consequent NO formation are well-recognized neuroinflammatory responses associated with Parkinson's disease (PD). These contribute to nitrosative protein modifications affecting neuronal injury and cell death. Indeed, a pathobiologic signature for PD is Lewy body formation containing misfolded and aggregated forms of alpha-synuclein (α-syn). Moreover, nitration of α-syn promotes protein aggregation in disease. To model such pathological events, we constructed controllable iNOS and bicistronic α-syn-IRES-tTA adeno-associated virus (AAV) expression vectors. Transduction of iNOS and α-syn AAV constructs led to nitration of α-syn in neurons and overexpression of iNOS promoted protein aggregation. We posit that this AAV system mimics critical protein misfolding events associated with the pathogenesis of PD.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22776646      PMCID: PMC3408780          DOI: 10.1016/j.neulet.2012.06.070

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  15 in total

1.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

Authors:  M Gossen; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

2.  Nitrated alpha-synuclein-activated microglial profiling for Parkinson's disease.

Authors:  Ashley D Reynolds; Jason G Glanzer; Irena Kadiu; Mary Ricardo-Dukelow; Anathbandhu Chaudhuri; Pawel Ciborowski; Ronald Cerny; Benjamin Gelman; Mark P Thomas; R Lee Mosley; Howard E Gendelman
Journal:  J Neurochem       Date:  2007-11-22       Impact factor: 5.372

3.  Dityrosine cross-linking promotes formation of stable alpha -synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies.

Authors:  J M Souza; B I Giasson; Q Chen; V M Lee; H Ischiropoulos
Journal:  J Biol Chem       Date:  2000-06-16       Impact factor: 5.157

4.  Dopaminergic neuron loss and up-regulation of chaperone protein mRNA induced by targeted over-expression of alpha-synuclein in mouse substantia nigra.

Authors:  Jessie L St Martin; Jochen Klucken; Tiago F Outeiro; Paul Nguyen; Christine Keller-McGandy; Ippolita Cantuti-Castelvetri; Tom N Grammatopoulos; David G Standaert; Bradley T Hyman; Pamela J McLean
Journal:  J Neurochem       Date:  2007-01-04       Impact factor: 5.372

5.  Nitration of tyrosine 10 critically enhances amyloid β aggregation and plaque formation.

Authors:  Markus P Kummer; Michael Hermes; Andrea Delekarte; Thea Hammerschmidt; Sathish Kumar; Dick Terwel; Jochen Walter; Hans-Christian Pape; Simone König; Sigrun Roeber; Frank Jessen; Thomas Klockgether; Martin Korte; Michael T Heneka
Journal:  Neuron       Date:  2011-09-08       Impact factor: 17.173

6.  Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2.

Authors:  C Knott; G Stern; G P Wilkin
Journal:  Mol Cell Neurosci       Date:  2000-12       Impact factor: 4.314

7.  Functional consequences of alpha-synuclein tyrosine nitration: diminished binding to lipid vesicles and increased fibril formation.

Authors:  Roberto Hodara; Erin H Norris; Benoit I Giasson; Amanda J Mishizen-Eberz; David R Lynch; Virginia M-Y Lee; Harry Ischiropoulos
Journal:  J Biol Chem       Date:  2004-09-09       Impact factor: 5.157

8.  Transfecting mammalian cells: optimization of critical parameters affecting calcium-phosphate precipitate formation.

Authors:  M Jordan; A Schallhorn; F M Wurm
Journal:  Nucleic Acids Res       Date:  1996-02-15       Impact factor: 16.971

9.  Diffusion of nitric oxide and scavenging by blood in the vasculature.

Authors:  A R Butler; I L Megson; P G Wright
Journal:  Biochim Biophys Acta       Date:  1998-09-16

10.  Nitrated alpha-synuclein immunity accelerates degeneration of nigral dopaminergic neurons.

Authors:  Eric J Benner; Rebecca Banerjee; Ashley D Reynolds; Simon Sherman; Vladimir M Pisarev; Vladislav Tsiperson; Craig Nemachek; Pawel Ciborowski; Serge Przedborski; R Lee Mosley; Howard E Gendelman
Journal:  PLoS One       Date:  2008-01-02       Impact factor: 3.240

View more
  11 in total

1.  The anti-inflammatory glycoprotein, CD200, restores neurogenesis and enhances amyloid phagocytosis in a mouse model of Alzheimer's disease.

Authors:  Megan M Varnum; Tomomi Kiyota; Kaitlin L Ingraham; Seiko Ikezu; Tsuneya Ikezu
Journal:  Neurobiol Aging       Date:  2015-08-01       Impact factor: 4.673

2.  Direct Detection of α-Synuclein Dimerization Dynamics: Single-Molecule Fluorescence Analysis.

Authors:  Zhengjian Lv; Alexey V Krasnoslobodtsev; Yuliang Zhang; Daniel Ysselstein; Jean-Christophe Rochet; Scott C Blanchard; Yuri L Lyubchenko
Journal:  Biophys J       Date:  2015-04-21       Impact factor: 4.033

Review 3.  Does restraining nitric oxide biosynthesis rescue from toxins-induced parkinsonism and sporadic Parkinson's disease?

Authors:  Satya Prakash Gupta; Sharawan Yadav; Naveen Kumar Singhal; Manindra Nath Tiwari; Sarad Kumar Mishra; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2013-07-31       Impact factor: 5.590

Review 4.  Preconditioning as a potential strategy for the prevention of Parkinson's disease.

Authors:  Mojtaba Golpich; Behrouz Rahmani; Norlinah Mohamed Ibrahim; Leila Dargahi; Zahurin Mohamed; Azman Ali Raymond; Abolhassan Ahmadiani
Journal:  Mol Neurobiol       Date:  2014-04-03       Impact factor: 5.590

5.  Lack of PINK1 alters glia innate immune responses and enhances inflammation-induced, nitric oxide-mediated neuron death.

Authors:  Liuke Sun; Ruifang Shen; Sandeep K Agnihotri; Yun Chen; Zhiwei Huang; Hansruedi Büeler
Journal:  Sci Rep       Date:  2018-01-10       Impact factor: 4.379

6.  Tubeimoside I Protects Dopaminergic Neurons Against Inflammation-Mediated Damage in Lipopolysaccharide (LPS)-Evoked Model of Parkinson's Disease in Rats.

Authors:  Dewei He; Bingxu Huang; Shoupeng Fu; Yuhang Li; Xin Ran; Yandan Liu; Guangxin Chen; Juxiong Liu; Dianfeng Liu
Journal:  Int J Mol Sci       Date:  2018-07-31       Impact factor: 5.923

Review 7.  Interaction between Parkin and α-Synuclein in PARK2-Mediated Parkinson's Disease.

Authors:  Daniel Aghaie Madsen; Sissel Ida Schmidt; Morten Blaabjerg; Morten Meyer
Journal:  Cells       Date:  2021-01-31       Impact factor: 6.600

8.  BHBA suppresses LPS-induced inflammation in BV-2 cells by inhibiting NF-κB activation.

Authors:  Shou-Peng Fu; Su-Nan Li; Jian-Fa Wang; Yang Li; Shan-Shan Xie; Wen-Jing Xue; Hong-Mei Liu; Bing-Xu Huang; Qing-Kang Lv; Lian-Cheng Lei; Guo-Wen Liu; Wei Wang; Ju-Xiong Liu
Journal:  Mediators Inflamm       Date:  2014-04-06       Impact factor: 4.711

9.  Entada africana fraction CH₂Cl₂/MEOH 5% inhibits inducible nitric oxide synthase and pro-inflammatory cytokines gene expression induced by lipopolysaccharide in microglia.

Authors:  Brice Ayissi Owona; Nico Frederic Njayou; Stefan A Laufer; Hermann J Schluesener; Paul Fewou Moundipa
Journal:  BMC Complement Altern Med       Date:  2013-10-03       Impact factor: 3.659

10.  AAV2/1 CD74 Gene Transfer Reduces β-amyloidosis and Improves Learning and Memory in a Mouse Model of Alzheimer's Disease.

Authors:  Tomomi Kiyota; Gang Zhang; Christine M Morrison; Megan E Bosch; Robert A Weir; Yaman Lu; Weiguo Dong; Howard E Gendelman
Journal:  Mol Ther       Date:  2015-07-31       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.